Abstract 4368690: Impact of Glycemic Control and Treatment in Maternal Diabetes on Congenital Heart Defects in Infants

Abstract

Background: Diabetes during pregnancy is a major risk factor for congenital heart disease (CHD), particularly septal defects and ventricular hypertrophy. Hemoglobin A1c (HbA1c) and the Oral Glucose Tolerance Test are screening measures used to diagnose and control diabetes in pregnancy. This retrospective study compares gestational and pre-gestational diabetes and CHD outcomes, the effects of glycemic control, diabetic treatment, and other maternal factors. Methods: Medical records of 217 infant-mother dyads from 2020-2024 were analyzed. Maternal HbA1C levels from the first and second trimesters were recorded. Fetal and postnatal echocardiograms were reviewed to identify CHD. An abnormal postnatal echocardiogram during the first three months of life was deemed to have CHD. Data was analyzed using descriptive statistics, logistic regression, and an ROC was calculated on HbA1C for the predictive value on CHD. Results: CHD was diagnosed in 21.7% of infants. Mean gestational age was 36 weeks 5 days (24-41 weeks) and mean maternal age was 32.6 years (18-45 years). Mean birth weight was 3096 grams (640-5465 grams). CHD was more common in those with pre-gestational diabetes than gestational diabetes 26.4% vs 15.6%; p = 0.055. The most frequent CHDs were atrial septal defect (44.7%), patent ductus arteriosus (36%), left ventricular hypertrophy (27.6%), and ventricular septal defect (22.3%). Among mothers, the classes of diabetes were type 2 diabetes (45%), gestational diabetes (44%), prediabetes (8.8%) and type 1 diabetes (2.3%). Logistic regression analysis showed that higher first-trimester HbA1c levels was significantly associated with an increased odd of CHD; OR 1.42 (CI: 1.10–1.86); p = 0.009. Second-trimester HbA1c levels were not significantly associated with CHD; p > 0.05. A decreasing trend in HbA1c and gestational age was significant for CHD, OR 0.81 (CI: 0.68-0.95); p = 0.012. The ROC curve for HbA1c resulted with an AUC of 0.67 (CI: 0.53-0.81); p = 0.015. Conclusion: Poor first-trimester glycemic control is significantly associated with an increased odds of CHD in infants born to diabetic mothers including gestational diabetes. Increasing gestational age and decreasing HbA1c trends are protective factors, emphasizing the importance of early pregnancy diabetes management. HbA1c levels are moderately predictive of CHD.